HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 87 filers reported holding HOMOLOGY MEDICINES INC in Q2 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $22,469 | -48.0% | 36,955 | 0.0% | 0.00% | -55.6% |
Q3 2023 | $43,238 | +32.2% | 36,955 | 0.0% | 0.01% | +28.6% |
Q2 2023 | $32,706 | -29.8% | 36,955 | 0.0% | 0.01% | -30.0% |
Q1 2023 | $46,564 | +0.0% | 36,955 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $46,563 | -21.1% | 36,955 | 0.0% | 0.01% | -28.6% |
Q3 2022 | $59,000 | -19.2% | 36,955 | 0.0% | 0.01% | -17.6% |
Q2 2022 | $73,000 | -34.8% | 36,955 | 0.0% | 0.02% | -32.0% |
Q1 2022 | $112,000 | -17.0% | 36,955 | 0.0% | 0.02% | -16.7% |
Q4 2021 | $135,000 | -53.6% | 36,955 | 0.0% | 0.03% | -53.8% |
Q3 2021 | $291,000 | +8.2% | 36,955 | 0.0% | 0.06% | +4.8% |
Q2 2021 | $269,000 | -22.7% | 36,955 | 0.0% | 0.06% | -34.0% |
Q1 2021 | $348,000 | -16.5% | 36,955 | 0.0% | 0.09% | -26.0% |
Q4 2020 | $417,000 | +5.6% | 36,955 | 0.0% | 0.13% | -4.5% |
Q3 2020 | $395,000 | -16.5% | 36,955 | +18.7% | 0.13% | -19.9% |
Q2 2020 | $473,000 | +0.9% | 31,136 | +3.1% | 0.17% | -7.8% |
Q1 2020 | $469,000 | – | 30,198 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,227,035 | $97,746,000 | 3.39% |
Vivo Capital, LLC | 1,159,742 | $21,687,000 | 3.07% |
SECTORAL ASSET MANAGEMENT INC | 225,000 | $4,208,000 | 0.46% |
Rock Springs Capital Management LP | 575,000 | $10,753,000 | 0.46% |
RTW INVESTMENTS, LP | 225,000 | $4,208,000 | 0.40% |
SPHERA FUNDS MANAGEMENT LTD. | 133,000 | $2,487,000 | 0.38% |
Temasek Holdings (Private) Ltd | 3,220,293 | $60,219,000 | 0.33% |
DC Investments Management, LLC | 21,436 | $401,000 | 0.27% |
ACUTA CAPITAL PARTNERS, LLC | 79,000 | $1,477,000 | 0.24% |
Monashee Investment Management LLC | 45,000 | $842,000 | 0.23% |